EUVIMEDEUVIMED entdecken
Crossref

Claims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor initiation in patients with triple-negative breast cancer in Japan

Chitose Kawamura, Masao Iwagami, Hiroko Bando

Breast Cancer · 11.11.2026

DOI: 10.1007/s12282-026-01940-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer, online erschienen am 11.11.2026. Verfasst von Chitose Kawamura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digital Health, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan. kawamura.chitose.ft@u.tsukuba.ac…. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Pfizer Health Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The incidence of treated adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor (ICI) treatment for triple-negative breast cancer (TNBC) has not been fully characterized in real-world clinical practice in Japan. METHODS: We conducted a retrospective cohort study using the JMDC claims database, which includes employees of Japanese companies and their dependents. Patients aged 18-74 years with TNBC who received atezolizumab or pembrolizumab between January 2005 and June 2025 were included. Early-stage and advanced TNBC were identified based on the treatment regimen at ICI initiation. We examined the incidence rates and time to onset of claims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes separately in the two cohorts. RESULTS: The study included 569 patients with early-stage TNBC (median age, 50.8 years) and 254 with advanced TNBC (median age, 52.8 years). In early-stage TNBC, the incidence rates (95% CIs) of adrenal insufficiency and hypothyroidism were 5.6 (4.0-7.8) and 12.7 (10.0-16.0) cases/100 person-years (PY), respectively. The median times to onset (IQRs) were 124 (86-215) and 117 (89-196) days, respectively. In advanced TNBC, the incidence rates (95% CIs) of adrenal insufficiency and hypothyroidism were 1.4 (0.53-3.8) and 9.2 (6.1-13.8) cases/100 PY, respectively. The median time to onset of hypothyroidism was 84 (63-105) days. Type 1 diabetes was rare. CONCLUSIONS: This study provides real-world estimates of claims-defined endocrine outcomes after ICI initiation separately in patients with early-stage and advanced TNBC in Japan.

Schlagwörter

Stichwörter der Autor:innen

Adrenal insufficiencyHypothyroidismImmune-related adverse eventsTriple-negative breast cancerType 1 diabetes

Autor:innen und Institutionen

  • Department of Digital Health, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan. kawamura.chitose.ft@u.tsukuba.ac.jp.
  • Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan. kawamura.chitose.ft@u.tsukuba.ac.jp.
  • Tsukuba Institute for Advanced Research, University of Tsukuba, Tsukuba, Ibaraki, Japan. kawamura.chitose.ft@u.tsukuba.ac.jp.
  • Department of Digital Health, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.
  • Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Department of Breast and Endocrine Surgery, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Förderung

  • Pfizer Health Research Foundation

Zitieren

APA

Kawamura, C., Iwagami, M., & Bando, H. (2026). Claims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor initiation in patients with triple-negative breast cancer in Japan. Breast Cancer. https://doi.org/10.1007/s12282-026-01940-6

Vancouver

Kawamura C, Iwagami M, Bando H. Claims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor initiation in patients with triple-negative breast cancer in Japan. Breast Cancer. 2026. doi:10.1007/s12282-026-01940-6

BibTeX
@article{Kawamura2026,
  author = {Kawamura, Chitose and Iwagami, Masao and Bando, Hiroko},
  title = {Claims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor initiation in patients with triple-negative breast cancer in Japan},
  journal = {Breast Cancer},
  year = {2026},
  doi = {10.1007/s12282-026-01940-6}
}
Kostenlos starten →